Literature DB >> 12815571

Prescription patterns of diuretics in chronic heart failure: a contemporary background as a clue to their role in treatment.

Pompilio Faggiano1, Cristina Opasich, Luigi Tavazzi, Felice Achilli, Anna Gentile, Luciano De Biase, Renata De Maria, Roberto Pozzi, Luigi Tarantini, Lucio Gonzini, Aldo P Maggioni.   

Abstract

BACKGROUND: Diuretics are the cornerstone of treatment for the congestive symptoms of heart failure (HF). Despite their widespread use, diuretic prescription data in clinical practice are scarce. In this study we evaluated the prescription pattern of diuretics in a large population of HF outpatients, enrolled by a national network of hospital-based cardiologists. METHODS AND
RESULTS: Among 11070 HF outpatients (mean age 64 +/- 12 years, 72.9% men, 29.8% New York Heart Association [NYHA] class III-IV, mean left ventricular ejection fraction [LVEF] 35+/-12%), 9247 took a diuretic, the most frequently prescribed therapeutic agent (83.5%). Loop diuretics were prescribed alone (65.5%) or combined with other diuretics in 91.6% of patients. By multivariate analysis, the strongest independent predictors of diuretic use were a previous hospital admission for HF (odds ratio [OR] 2.55, 95% confidence interval [CI] 2.28-2.86), NYHA class III-IV (OR 2.52, 95% CI 2.14-2.96), LVEF < 30% (OR 1.87, 95% CI 1.57-2.24). Aldosterone antagonists were prescribed to 2142 patients (23.1%); independent predictors of their use overlapped with those of diuretics and moreover included treatment with loop diuretics (OR 3.52, 95% CI 2.66-4.66) and digoxin (OR 1.45, 95% CI 1.29-1.64).
CONCLUSIONS: In this wide series of stable HF outpatients, cardiologists prescribed diuretics in accordance with published guidelines. Evolving prescription patterns of aldosterone-receptor blockers need to be further evaluated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815571     DOI: 10.1054/jcaf.2003.25

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  4 in total

1.  Implementation of evidence-based therapy in patients with systolic heart failure from 1998-2000.

Authors:  R Reibis; C Dovifat; R Dissmann; B Ehrlich; S Schulz; K Stolze; K Wegscheider; H Völler
Journal:  Clin Res Cardiol       Date:  2006-01-19       Impact factor: 5.460

Review 2.  Impact of Loop Diuretic on Outcomes in Patients with Heart Failure and Reduced Ejection Fraction.

Authors:  Cicoira Maria Antonietta; Emiliano Calvi; Andrea Faggiano; Caterina Maffeis; Marco Bosisio; Marco De Stefano; Stefano Carugo; Pompilio Faggiano
Journal:  Curr Heart Fail Rep       Date:  2022-01-17

3.  Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.

Authors:  Jozine M Ter Maaten; Pieter Martens; Kevin Damman; Kenneth Dickstein; Piotr Ponikowski; Chim C Lang; Leong L Ng; Stefan D Anker; Nilesh J Samani; Gerasimos Filippatos; John G Cleland; Faiez Zannad; Hans L Hillege; Dirk J van Veldhuisen; Marco Metra; Adriaan A Voors; Wilfried Mullens
Journal:  Clin Res Cardiol       Date:  2020-01-30       Impact factor: 5.460

4.  Prescription Practices in Patients With Mild to Moderate CKD in India.

Authors:  Narayan Prasad; Ashok Kumar Yadav; Monica Kundu; Jasmin Sethi; Ajay Jaryal; Dipankar Sircar; Gopesh K Modi; Kajal Kamboj; Manisha Sahay; Natarajan Gopalakrishnan; Prabhjot Kaur; Sanjay Vikrant; Santosh Varughese; Seema Baid-Agrawal; Shivendra Singh; Sishir Gang; Sreejith Parameswaran; Vivek Kumar; Arpita Ghosh; Vivekanand Jha
Journal:  Kidney Int Rep       Date:  2021-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.